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Abstract
Mammalian ageing is associated with reduced regenerative capacity in tissues that contain stem
cells1,2. It has been proposed that this is at least partially caused by the senescence of progenitors
with age3,4; however, it has not yet been tested whether genes associated with senescence
functionally contribute to physiological declines in progenitor activity. Here we show that progenitor
proliferation in the subventricular zone and neurogenesis in the olfactory bulb, as well as multipotent
progenitor frequency and self-renewal potential, all decline with age in the mouse forebrain. These
declines in progenitor frequency and function correlate with increased expression of p16INK4a, which
encodes a cyclin-dependent kinase inhibitor linked to senescence5. Ageing p16INK4a-deficient mice
showed a significantly smaller decline in subventricular zone proliferation, olfactory bulb
neurogenesis, and the frequency and self-renewal potential of multipotent progenitors. p16INK4a
deficiency did not detectably affect progenitor function in the dentate gyrus or enteric nervous system,
indicating regional differences in the response of neural progenitors to increased p16INK4a expression
during ageing. Declining subventricular zone progenitor function and olfactory bulb neurogenesis
during ageing are thus caused partly by increasing p16INK4a expression.
Stem cells must persist throughout adult life in numerous tissues, including the central nervous
system (CNS)6, in order to replace the mature cells that are lost to turnover, injury, or disease.
However, the function of stem cells and other progenitors declines with age in diverse tissues
including the haematopoietic system7–9, muscle10,11 and brain6,12,13. Consistent with this,
ageing tissues exhibit reduced repair capacity and an increased incidence of degenerative
disease1,4. However, the mechanisms responsible for the age-related decline in the function
of stem cells and other progenitors remain uncertain.
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p16INK4a gene expression increases with age in a variety of tissues14–16. Although induction
of p16INK4a expression can cause the senescence of a variety of cell types in culture5,17 and
in vivo18, some cells (including some neural progenitors) are unaffected by increased
p16INK4a expression or p16INK4a deletion19–21. It is thus unclear whether increased
p16INK4a expression causes declines in progenitor function during ageing in vivo. We have
addressed this question by examining progenitor frequency, proliferation and neurogenesis in
the forebrain lateral ventricle subventricular zone (SVZ) of ageing wild-type and p16INK4a-
deficient mice. The SVZ contains a mixed population of stem cells and other progenitors that
engage in neurogenesis throughout adult life6,13,22. The rate of neurogenesis is known to
decline in ageing mammals13, but the physiological mechanisms responsible for this decline
have not been identified.
We compared various measures of progenitor function in the SVZ of 60-day-old, 1-yr-old and
2-yr-old mice to determine the effects of ageing. Consistent with a previous study6, we found
a twofold reduction with age in the frequency of SVZ cells that formed multipotent
neurospheres in culture (Fig. 1a; asterisk, P < 0.05). This was associated with an approximately
twofold reduction in the self-renewal potential of these multipotent neurospheres (Fig. 1b;
asterisk, P < 0.05). In vivo, we observed an approximately threefold reduction in the rate of
proliferation in the SVZ with age (Fig. 1c, d; asterisk, P < 0.05). These data suggest that stem
cell frequency and self-renewal potential, as well as overall proliferation rate, decline with age
in the SVZ.
Adult Bmi1-deficient mice also exhibit reduced stem cell frequency and self-renewal potential,
as well as reduced proliferation in the SVZ20. These effects are largely caused by increased
p16INK4a and Arf expression in the absence of Bmi1 (refs 19–21). We therefore wondered
whether the age-related changes observed in wild-type mice (Fig. 1) were associated with
increased p16INK4a or Arf expression in neural progenitors. p16INK4a and Arf expression
increase with age in some tissues15,16, although these studies did not examine neural
progenitors. We did not detect any age-related increase in Arf expression in uncultured SVZ
cells at the RNA or protein levels (data not shown). In contrast, p16INK4a expression increased
substantially with age in uncultured SVZ cells (Fig. 1e). p16INK4a expression was not detectable
by polymerase chain reaction (PCR) in the SVZ of 60-day-old mice, but became detectable by
1 yr of age and further increased by 2 yr of age. We were not able to detect p16INK4a protein
in the SVZ by western blot, consistent with previous studies that have also not been able to
detect this protein in most uncultured mouse tissues that express p16INK4a mRNA15,16,
presumably due to its low expression level and the limited sensitivity of available antibodies.
To test the function of p16INK4a in ageing neural progenitors we examined young (60-day-old)
and old (2-yr-old) p16INK4a-deficient mice as well as littermate controls. p16INK4a deficiency
did not grossly affect the composition of the SVZ, with similar proportions of SVZ cells
staining positively for the glia marker GFAP or the neuroblast marker doublecortin in wild-
type and p16INK4a-deficient mice irrespective of age (data not shown). Similarly, apoptotic
SVZ cells (activated caspase-3+) were rare in all treatments (data not shown). Deletion of
p16INK4a in young mice did not significantly affect the frequency of SVZ cells that formed
multipotent neurospheres in culture (Fig. 2a), or the self-renewal potential of these cells upon
subcloning (Fig. 2b). This is consistent with our failure to detect p16INK4a expression in SVZ
cells from young mice in vivo, as well as with previous studies19,20. In contrast, p16INK4a
deficiency in old mice significantly increased the frequency of SVZ cells that formed
multipotent neurospheres in culture (Fig. 2a; hash, P < 0.05 relative to old wild-type mice), as
well as the self-renewal potential of these cells (Fig. 2b; hash, P < 0.05 relative to old wild-
type mice). Consistent with this finding, the rate of proliferation among SVZ cells in vivo was
also significantly increased by p16INK4a deficiency in old but not young mice (Fig. 2c; hash,
P < 0.05 relative to old wild-type mice). Nonetheless, the percentage of proliferating cells in
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old p16INK4a-deficient mice was still significantly less than observed in normal or p16INK4a-
deficient young mice (Fig. 2c; asterisk, P < 0.05 relative to young mice). Like old wild-type
mice, old p16INK4a-deficient mice also exhibited enlarged lateral ventricles due to cortical
atrophy (Fig. 1c, data not shown). These observations indicate that p16INK4a deficiency
partially rescued the age-related declines in progenitor activity in the SVZ but did not prevent
cortical atrophy.
p16INK4a deficiency seemed to rescue completely the age-related decline in cells that can form
stem cell colonies in culture (Fig. 2a), while only partially rescuing the overall decline in SVZ
proliferation (Fig. 2c). One possibility that would be consistent with previous studies of
p16INK4a in neural progenitors19–21 is that p16INK4a expression had a greater effect on SVZ
stem cells than on downstream progenitors. A number of studies have argued that stem cells
can be identified within the SVZ based on their ability to retain the DNA replication label 5-
bromodeoxyuridine (BrdU; stem cells divide infrequently and are retained within the SVZ
while other progenitors divide continuously before migrating out of the SVZ)22–25. Therefore,
we examined the effects of age and p16INK4a deficiency on the frequency of BrdU label-
retaining cells. We administered BrdU for 8 days, followed by a 4-week chase with no BrdU,
then killed the mice. p16INK4a deficiency had no effect on the frequency of label-retaining cells
in the young adult SVZ (Fig. 2d). The frequency of label-retaining cells declined significantly
in old wild-type mice but not in old p16INK4a-deficient mice (Fig. 2d). Thus, the frequencies
of label-retaining cells in vivo exhibited similar trends as observed for the frequencies of cells
that could form multi-lineage colonies in culture. These data suggest that p16INK4a deficiency
can largely rescue the age-related decline in the frequency of early progenitors within the SVZ.
SVZ progenitors form neuroblasts throughout life that migrate into the olfactory bulb and
differentiate into neurons13,22. To test whether the increase in p16INK4a expression within the
SVZ also affects neurogenesis, we examined the effects of age and p16INK4a deficiency on the
generation of new neurons in the olfactory bulb. We administered BrdU to mice for 8 days to
mark dividing progenitors, followed by a 4-week chase period with no BrdU (during which
neurons could migrate and differentiate), then killed the mice to analyse sections through the
olfactory bulb by confocal microscopy. As we observed for progenitor function, p16INK4a
deficiency had no effect on neurogenesis in young mice, but neurogenesis significantly
decreased with age, and p16INK4a deficiency significantly increased the frequency of newly
generated olfactory bulb neurons in 15–19-month-old mice (Fig. 3i). Notably, p16INK4a
deficiency had no effect on the frequency of non-neuronal cells within the olfactory bulb (Fig.
3j). This may at least partially reflect our previous obserpvation that changes in p16INK4a
expression do not appear to affect gliarestricted progenitors20. p16INK4a deficiency thus
partially rescued the age-related decline in neurogenesis in the olfactory bulb in addition to
rescuing partially the decline in progenitor function in the SVZ.
To test whether these effects of p16INK4a occurred throughout the CNS, we also examined the
effect of p16INK4a deficiency on progenitor activity and neurogenesis in the dentate gyrus26.
The rates of progenitor proliferation and neurogenesis in the dentate gyrus decline markedly
with age12. To test whether this is affected by p16INK4a, we administered BrdU for 8 days to
mark proliferation in the subgranular layer, followed by a 4-week chase period without BrdU
to examine neurogenesis in the granular layer. p16INK4a deficiency did not significantly affect
the rate of proliferation among progenitors in the subgranular layer, or the frequency of
BrdU+NeuN+ newly generated neurons or BrdU+NeuN− non-neuronal cells in the granular
layer of the dentate gyrus (Supplementary Fig. 1). Thus, although p16INK4a deficiency
consistently increased all measures of progenitor activity and neurogenesis in the ageing
subventricular zone/olfactory bulb, it did not detectably affect proliferation or neurogenesis in
the dentate gyrus.
Molofsky et al. Page 3













We also examined the effect of age and p16INK4a deficiency on the neural crest stem cells that
persist throughout adult life in the enteric nervous system (in the gut wall)19,20,27. The
frequency of these neural crest stem cells declined with age, and p16INK4a expression increased
with age in p75+ (neurotrophin-receptor expressing) gut cells enriched for neural crest stem
cells (Supplementary Fig. 2). However, p16INK4a deficiency had no effect on neural crest stem
cell frequency in young or old mice. These results indicate that although the age-related
increase in p16INK4a expression causes a decline in SVZ progenitor function and neurogenesis,
other mechanisms are more important in the ageing of stem and progenitor cells in the
hippocampus and peripheral nervous system.
The mechanisms that account for the increase in p16INK4a expression with age remain unclear.
In principle, p16INK4a expression could be developmentally programmed to increase with age
to counter the increasing incidence of cancer that is observed in the ageing nervous system.
Alternatively, p16INK4a expression may reflect the induction of senescence in ageing cells in
response to damage that accumulates from oxidative metabolism or other stresses. Although
Bmi1 is important for p16INK4a repression19,20,28, we did not detect any change in Bmi1
expression with age at the RNA or protein levels in SVZ cells (Supplementary Fig. 3).
Nonetheless, subtle reductions in Bmi1 expression or activity cannot be excluded and could
be functionally important, as even the twofold reduction in Bmi1 expression in Bmi1−/+ mice
leads to increased p16INK4a expression (data not shown). Additional work will be required to
resolve the potentially multifactorial mechanisms that regulate age-related changes in
p16INK4a expression.
The simplest interpretation of our data is that p16INK4a acts cell autonomously within neural
stem cells, because p16INK4a deficiency increased the self-renewal of single neural stem cells
in culture. However, we cannot exclude the possibility of non-cell-autonomous effects by
p16INK4a in vivo. In addition to investigating this issue further, it will also be of interest to
determine whether circulating humoral factors11 influence p16INK4a expression during ageing.
One study found that moderately increased expression of p16INK4a and p19ARF in transgenic
mice does not detectably accelerate gross measures of ageing or change lifespan, despite
reducing cancer incidence29. However, that study did not examine neural progenitor function
or neurogenesis. We also examined p16INK4a bacterial artificial chromosome (BAC) transgenic
mice that exhibited a moderate increase in p16INK4a expression and found no effect of
p16INK4a overexpression on stem cell frequency or self-renewal potential, although old
transgenic mice did exhibit a modest reduction in SVZ proliferation (data not shown). It seems
that the levels of p16INK4a that are required to deplete stem cells are qualitatively higher than
the levels that are required to inhibit carcinogenesis. Together, the data suggest that although
physiological increases in p16INK4a expression during ageing reduce neural progenitor function
and neurogenesis in the SVZ/olfactory bulb, modest overexpression of p16INK4a does not
substantially amplify these effects or accelerate gross measures of ageing.
Although physiological p16INK4a expression reduces stem/progenitor cell function and
neurogenesis with age, how this relates to overall ageing or lifespan remains unclear. It is
difficult to examine the effect of p16INK4a deficiency on mouse lifespan because p16INK4a
deficiency increases cancer incidence30 in addition to affecting age-related changes in stem/
progenitor cell function. Declining stem/progenitor cell function may be a major cause of the
decline in regenerative capacity and the increase in degenerative disease that is observed in
ageing tissues. On the other hand, increases in the death or dysfunction of mature cells in ageing
tissues also contribute to age-related morbidity. It is similarly unknown whether physiological
differences in the rate at which stem/progenitor cell activity declines with age has a detectable
impact on longevity. The fact that p16INK4a did not affect progenitors in certain regions of the
nervous system suggests that p16INK4a is not likely to promote generically the ageing of all
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cells. Indeed, it is likely that there will be important differences between tissues, and perhaps
between progenitor cells and differentiated cells, in terms of the genes that regulate the ageing
process. Although these questions remain unanswered, it may be possible to gain important
new insights into the ageing process at a cellular level by studying individual cell types that
have known physiological functions in vivo, such as haematopoietic or neural stem cells.
Our data suggest that stem cell function is regulated by a balance between proto-oncogenes,
like Bmi1 (that promote stem cell maintenance and regenerative capacity but can also contribute
to neoplastic proliferation), and tumour suppressors, like p16INK4a (that reduce regenerative
capacity and promote ageing but also reduce cancer incidence). This balance changes with age
and is influenced by other proto-oncogenes and tumour suppressors that also regulate
p16INK4a expression. The networks of proto-oncogenes and tumour suppressors that regulate
stem cell self-renewal, cancer cell proliferation and stem cell ageing may have evolved to
balance the need for regenerative capacity while guarding against the increasing risk of
neoplasms with age. p16INK4a thus reduces cancer incidence5,30 but also contributes to ageing




p16INK4a+/− mice were backcrossed at least six times onto a C57BL background. p16INK4a
genotyping was performed by PCR as described30.
Isolation of CNS progenitors
Adult SVZ was obtained by microdissecting the lateral walls of the lateral ventricles, then
dissociating for 20 min at 37 °C in 0.025% trypsin/0.5 mM EDTA (Calbiochem) plus 0.001%
DNase1 (Roche). After quenching the enzymatic dissociation with staining medium (L15
medium containing 1 mg ml− BSA (Sigma A-3912), 10 mM HEPES (pH 7.4) and 1% penicillin/
streptomycin (BioWhittaker)) containing 0.014% soybean trypsin inhibitor (Sigma) and
0.001% DNase1, the cells were washed and re-suspended in staining medium, triturated,
filtered through nylon screen (45μm, Sefar America), counted by haemocytometer, and plated.
Cell culture and self-renewal assay
Cells were plated at clonal density (1.3 cells per μl) on ultra-low-binding plates (Corning) to
grow neurospheres. Culture medium was based on a 5:3 mixture of DMEM-low glucose as
described previously19: neurobasal medium (Gibco) supplemented with 20 ng ml−1 human
bFGF (R&D Systems), 20 ng ml−1 EGF (R&D Systems), 1% N2 supplement (Gibco), 2% B27
supplement (Gibco), 50μM 2-mercaptoethanol, 1% penicillin/streptomycin (Biowhittaker),
and 10% chick embryo extract. Cultures were maintained at 37 °C in 6% CO2/balance air. To
measure self-renewal, individual neurospheres were dissociated by trituration then replated at
clonal density as above. Secondary neurospheres were counted 5–10 days later to determine
the number of secondary neurospheres formed per primary neurosphere. CNS neurospheres
were tested for multipotency by replating one neurosphere per well into 48-well plates and
then culturing adherently for 3–5 days before triple staining for oligodendrocytes (O4), neurons
(TuJ1) and astrocytes (GFAP). See Supplementary Methods for details.
BrdU incorporation/proliferation assays
To quantify SVZ proliferation, mice were injected intraperitoneally with 50 mg kg−1 of BrdU
(Sigma), and killed 2 h after BrdU injection. To quantify proliferation in the dentate gyrus,
mice received a single injection of 50 mg kg−1 BrdU, followed by 1 mg ml−1 BrdU in their
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drinking water for 8 days before being killed and analysed. To quantify neurogenesis in the
dentate gyrus and the olfactory bulb and BrdU retention in the SVZ, mice were treated with
BrdU for 8 days. However, the animals were then taken off of BrdU for 4 weeks before the
animals were killed. The brains were dissected, fixed in 4% paraformaldehyde overnight, then
cryo-protected in 15% sucrose, embedded in 7.5% gelatin/15% sucrose, and flash frozen.
Twelve-micrometre sections were cut on a Leica cryostat.
For detection of BrdU in the tissue sections, DNA was denatured in 2 M HCl for 30 min at
room temperature and neutralized with 0.1 M sodium borate. Sections were pre-blocked for 1
h at room temperature in goat serum solution (PBS containing 5% goat serum, 1% BSA and
0.3% Triton X-100 (Sigma)). Primary rat anti-BrdU (1:500, Accurate Chemical) diluted in goat
serum solution was incubated overnight at 4 °C, followed by fluorescein isothiocyanate
(FITC)-conjugated anti-rat Fc fragment (Jackson Labs) for 3–4 h at room temperature. Slides
were counter stained in 2.5μg ml−1 DAPI for 10 min at room temperature, then mounted using
ProLong antifade solution (Molecular Probes). Numbers of BrdU-labelled cells were divided
by total DAPI+ or NeuN+ nuclei.
To ensure that BrdU incorporation results were not skewed by dividing endothelial or
haematopoietic cells, we double-labelled SVZ sections with antibodies against BrdU and either
anti-CD45 (to identify blood cells) or anti-VE-cadherin (to identify endothelial cells). We did
not detect any BrdU+ haematopoietic or endothelial cells.
Western blots and quantitative RT–PCR were performed as described in Supplementary
Information.
Statistical analysis
Experiments that involved multiple treatments were initially analysed by analysis of variance.
Statistically significant results were followed up with Student’s t-tests.
Confocal analysis of neurogenesis in the olfactory bulb
A Zeiss LSM 510 confocal laser-scanning microscope was used to obtain 25–30 random fields
of view throughout all regions of one entire olfactory bulb of each mouse with a ×40 or ×63
objective lens. For each image, 1-μm-thick optical sections were scanned with three different
lasers through a 12-μm sagittal tissue section creating a Z-series stack with three distinct
channels of fluorescence. An ultraviolet enterprise laser was used to detect the DAPI signal
labelling all nuclei. An argon laser detected FITC (BrdU), and a HeNe laser detected Cy3
(NeuN). Channels were merged together to determine whether DAPI, BrdU and NeuN signals
co-labelled at every 1-μm slice of the Z-series. Three-dimensional projections were made using
LSM 510 software.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Neural progenitor function declines with age
a, The percentage of SVZ cells that formed multipotent neurospheres in culture declined with
age (asterisk, P < 0.05 relative to 60-day-old mice; three independent experiments; 5–6 mice
per age; error bars for all panels are ±s.d.). b, The self-renewal potential of these primary
neurospheres also declined with age (asterisk, P < 0.05; three independent experiments; 5–6
mice per age). c, d, Proliferation in the SVZ (percentage of BrdU+ cells after a 2-h pulse) also
declined significantly with age (three mice per age; 5–7 sections per mouse). The SVZ thinned
in old mice (c, arrows), and the lateral ventricle expanded (asterisk) due to cortical atrophy
(c, lateral ventricle is not visible at this magnification in young mice; scale bar, 200μm). e,
p16INK4a mRNA expression increased with age as detected by quantitative (real-time) PCR in
uncultured SVZ cells (three independent samples per age). Note that 1-yr-old samples were
set to 1.0 as the reference sample. ND, not detected.
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Figure 2. p16INK4a causes age-related declines in stem and progenitor cell function in the SVZ
a, The percentage of SVZ cells that formed multipotent neurospheres in culture significantly
declined in 2-yr-old wild-type mice as compared with 60-day-old mice (asterisk, P < 0.01) but
significantly increased in old mice with p16INK4a deficiency (hash, P < 0.01 relative to old
wild-type mice). b, Self-renewal potential (the number of secondary neurospheres generated
per subcloned primary neurosphere) significantly declined in old wild-type mice as compared
to young mice (asterisk, P < 0.05). p16INK4a deficiency significantly increased the self-renewal
of neurospheres from old but not young mice (hash, P < 0.05 relative to old wild-type mice).
c, The percentage of SVZ cells that incorporated a 2-h pulse of BrdU significantly declined in
old as compared to young mice (asterisk, P < 0.01), but significantly increased in old mice
with p16INK4a deficiency (hash, P < 0.01 relative to old wild-type mice). d, The frequency of
BrdU label-retaining cells in the SVZ significantly declined in old wild-type mice as compared
with young wild-type mice (asterisk, P < 0.05), but significantly increased in old mice with
p16INK4a deficiency (hash, P < 0.05 relative to old wild-type mice). All values are mean ± s.d.
for at least three independent experiments. All mice were histologically negative for
intracranial neoplasms.
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Figure 3. p16INK4a causes age-related declines in olfactory bulb neurogenesis
a–d, Low-magnification images (scale bar, 20μm) from sagittal sections of the olfactory bulb
of old wild-type (a, b; same field of view) and p16INK4a-deficient (c, d; same field of view)
mice. Arrows point to new neurons in the granular layer (BrdU+NeuN+) whereas arrowheads
point to new non-neuronal cells (BrdU+NeuN−). e–h, Higher magnification images (scale bar,
10μm) from one field of view from an old p16INK4a-deficient mouse. Arrow indicates
BrdU+NeuN+ neuron; arrowhead indicates BrdUþNeuN2 non-neuronal cell. Panel h is a three-
dimensional, reconstructed side view (80° turn in the z-axis) of panel g. i, Neurogenesis
significantly (asterisk, P < 0.05) declined with age (BrdU+NeuN+ neurons as a percentage of
all NeuN+ neurons). p16INK4a deficiency did not affect the level of neurogenesis in young mice,
but significantly (hash, P = 0.02 relative to old wild-type mice) increased neurogenesis in old
mice. j, The frequency of BrdU+NeuN− non-neuronal cells was not significantly affected by
p16INK4a deficiency (also as a percentage of NeuN+ neurons). The same trends were observed
when the counts were expressed per unit area (not shown). Values are mean ± s.d. from 25 to
30 fields of view per mouse, three mice per treatment.
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